ConductScience.org, home

Trial · NCT07881523

Ultrasound-Guided Midpoint Transverse Process to Pleura Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Open Renal Surgery :A Randomized Comparative Study.

NCT07881523, Not applicable, Not yet recruiting, Minia University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Ultrasound-Guided Midpoint Transverse Process to Pleura Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Open Renal Surgery :A Randomized Comparative Study. Trials, record NCT07881523. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881523

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Ultrasound-Guided Midpoint Transverse Process to Pleura Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Open Renal Surgery :A Randomized Comparative Study.
NCT number
NCT07881523
Status
Not yet recruiting
Phases
Not applicable
Enrollment
50 participants, estimated
Lead sponsor
Minia University
Conditions
Postoperative Analgesia in Patients Undergoing Open Renal Surgery
Interventions
Midpoint Transverse Process to Pleura (MTP)Block, Erector spinae plane (ESP) block
First posted
2026-10-19
Last updated
2026-10-19

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe primary outcome is the total postoperative opioid consumption, expressed as I.V. Nalbuphine in mg in the first 24 hour postoperatively.the first 24 hour postoperativelymeasure I.V. Nalbuphine in mg in the first 24 hour postoperatively
SecondaryTime to first analgesic requesttime from end of surgery to first request of rescue analgesia accessed by minutes (assessed during the first 24 hours postoperatively.First Analgesic Request: time from end of surgery to first request of rescue analgesia accessed by minutes, if pain persists (NRS ≥ 4) nalbuphine 3mg IV will be given as a rescue analgesia.
SecondaryPostoperative pain assessmentimmediately after surgery, after 2hr, 4hr,6hr,8hr,12hr,16hr,20hr,24hr
using the Numeric Rating Scale (NRS) at rest and during movement .Pain intensity will be assessed by asking patients to rate their current pain by selecting a number from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. The scale was explained to all patients prior to assessment to ensure understanding. No pain: 0 Mild pain: 1-2 Moderate pain: 4-6 Severe pain: 7-10

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07881523

GET https://conductscience.org/api/trials/v1/NCT07881523/registered